Date post: | 29-Jul-2016 |
Category: |
Documents |
Upload: | instradent |
View: | 222 times |
Download: | 2 times |
Access to reliability
and predictability
INSTRADENT® Regenerative solutions
INSTRADENT® XENOGRAFT
Reliable bone volume1–9
Similar to human bone, the Instradent® XenoGraft is a Deproteinized Bo vine
Bone Mineral (DBBM) with low cristallinity, high porosity and an optimal
balance of calcium and phosphate designed to achieve reliable bone volume
in guided bone regeneration ultimately achieving esthetic results.
02 | Instradent hard tissue
EXCELLENT BIOCOMPATIBILITY
§Optimal balance of calcium and
phosphate comparable to human bone.
§ Apatite structure deproteinized,
delipidized, and sterilized via gamma
irradiation.
FLEXIBLE PROCEDURE
§ Can be mixed with either autogenous or
allograft bone.
§ Combine with the Instradent Membrane
to maintain ideal space and long-term cell
occlusion for maximizing bone volume.
PREDICTABLE BONE VOLUME
§ Consistent particle size creating a predic-
table scaffold with a favorable tactile feel
when drilling.
§ Slow resorption rate helping to achieve
long term volume.
OPTIMAL BONE REGENERATION
§ Low crystallinity providing a favorable
surface to which new bone can adhere.
§ High porosity supporting the osteo-
conduction for having a structural
scaffold for vascular ingrowth and
bone formation.
Step 1:
Bovine bone
ground to
particulate
Step 2:
Lipids and proteins
removed through
vigorous washes and
high-temperature
Step 3:
Low crystallinity
achieved at 600° to
create a favorable
surface to which
bone can adhere
Step 4:
Terminal
sterilization
via gamma
irradiation
Processing assures biocompatibility
Instradent® XenoGraft is methodically processed from bovine bone and extensively tested to
eliminate antigenicity and provide a favorable environment for new bone growth. Indeed, the
granules have been treated at 600°C to achieve a low crystallinity, high content of carbonate
ions, and porous structure which showed a better osteo conductivity comparing to granules
treated with a higher temperature.3
0
70,10 67,8965,02
68,3765,25
63,21
The Instradent® XenoGraft is comparable to the standard DBBM with a low cristalinity and
similar particles size and porosity. Additionally, the Instradent® XenoGraft provides a comparable
Ca/P ratio to the human bone for an optimal biocompatibility and has consistent particle size
for having the reliable framework for new bone growth and for achieving bone volume.
Instradent hard tissue | 03
The clinical study showed that over time there was no statistically sig-
nificant difference between the two bone grafting materials. The two
bone grafting materials show comparable resorption results with no
statistically significant differences when used in sinus lift procedures.9
The Instradent® XenoGraft shows in clinical trial or in a preclinical study its successful outcomes
in Guided Bone Regeneration (GBR) improving key clinical parameters.
0
4,48
7,66
11,52
3,09
9,25
5,73
New bone (%)
Graft (%)
Competitor DBBM Instradent XenoGraft
25
-50
-25
0
Competitor DBBM Instradent XenoGraft
A radiographical study on the changes in height of grafting
materials after sinus lift9
Histomorphometric analysis, preclinical study14
2 weeks 4 weeks 8 weeks
Mole ratio of Ca/P14
1,50
1,60
1,70
1,68 1,68
1,59
Human bone Competitor DBBM Instradent XenoGraft
Competitor DBBM Instradent XenoGraft
Competitor DBBM Instradent XenoGraft
× 20× 20
100
50
0
0,8 – 1,0mm 0,4 – 0,8mm 0,2 – 0,4mm 0,1 – 0,2mm
5,6%2%
63,6%
96%
30,5%
1% 0,3%
Competitor DBBM Instradent XenoGraft
Particle size distribution14
SCIENCE
Nanocrystalline surface structure
Small granules (0.2 – 1.0mm)
Large granules (1.0 – 2.0mm)
Processing assures biocompatibility
Instradent® Collagen Membrane is meticulously manufactured from highly purified native
collagen, ideal choice for the excellent biocompatibility and capacity to enhance wound
healing process. The cross-linking has been achieved without chemicals (such as formal-
dehyde and glutaraldehyde) to avoid any adversely influences on surrounding tissues or
leave of cytotoxic residue during the process.12, 13
Step 5:
Drying and
packaging
Step 6:
End gamma
radiation
sterilization
Step 1:
Processed
collagen
from porci-
ne dermis
Step 2:
Washing
to remove
processing
residues
Step 3:
Interlaced for
crosslinking
increases
mechanical
strength
Step 4:
Washing
to remove
residues
crosslinked
INSTRADENT® MEMBRANE
Predictable regeneration10–14
04 | Instradent soft tissue
EASY-TO-HANDLE AND QUICK
APPLICATION
§ Either side can be placed dry or hydrated,
so not side specific.
§ Easily repositionable for precise
placement.
OPTIMAL BARRIER FUNCTION
§ Cross-linked collagen without chemicals
allowing a slow and predictable barrier
resorption rate from 4 to 6 months provi-
ding ideal condition for bone growth.
§ Fibrous structure enabling cell occlusion
supporting bone regeneration, pro-
tecting the graft area of unwanted
soft tissue infiltrations during the
initial healing phase.
FLEXIBLE PROCEDURE
§ Can be placed in conjunction with any
bone grafting material or as a standalone
solution.
§ Available in 3 different sizes.
STABILITY FOR OPTIMAL BONE HEALING
§ High tear resistance allowing a wide
variety of fixing methods, including pins
and sutures enhancing undisturbed bone
regeneration site.
§Multi-layers structured of type 1 collagen
providing bone healing stability and
soft tissue support.
Instradent® Collagen Membrane (type I) is a porous non-chemical cross-
linking porcine- derived (dermis) fibrous membrane designed to achieve
predictable guided bone regeneration and tissue regeneration.
44,8
56,2
64,3
53,2
61,6
0
60
4 weeks 8 weeks 16 weeks
20
40
41,3
The Instradent® Collagen Membrane shows in a randomized clinical trial or in a preclinical study
its successful outcomes in Guided Tissue Regeneration (GTR) or in Guided Bone Regeneration
(GBR) improving key clinical parameters.
SCIENCE
Instradent soft tissue | 05
The Instradent® Collagen Membrane has a multi-layer fibrous structure designed for acting as
a cell occlusive barrier which protects the healing site. The porous surface is designed to helps
vascularization enhancing the soft and hard tissue healing. Additionally, its high tear resistance
preserves undisturbed the bone regeneration site.
-3,6
-5,1
2,5
3,6
5,0
5,8
Plaque index change
Clinical attachement
level gain
Bone Fill
Competitor: Bilayer collagen membrane Instradent collagen membrane Competitor: Bilayer collagen membrane Instradent collagen membrane
Run 1 Run 2 Run 3
4,4
0
10
20
16,1
4,7
14,8
4,7
16,6
Competitor: Bilayer collagen membrane Instradent collagen membrane
Tensile strength 14
(in N/mm2)
New bone formation in a preclinical study14
(in %)
Surface view | × 1.50k
Competitor: Bilayer collagen membrane Instradent collagen membrane
Cross-sectional view | × 500
Randomized clinical trial in periodontal intrabony
defects, 3 months results 11
(in mm)
Instradent® XenoGraft
Granule size Package volume
0.2 mm 0.25 g, 0.50 g, 1.0 g, 2.0 g
1.0 mm 0.25 g, 0.50 g, 1.0 g, 2.0 g
2.0 mm 0.25 g, 0.50 g, 1.0 g, 2.0 g
Storage
15°C – 25°C, dry place
Shelf life
3 years
PRODUCT AVAILABILITY
References :
1. A study on the safety and efficacy of bovine bone-derived bone graft material (OCS-B). J Korean Acad Periodontol.
2005 Jun;35(2):335-343. 2. Evaluation on the bone regenerative capacity of deproteinized bovine bone-derived bone graft
material (OCS-B). The Journal of the Korean Dental Association. Vol.44 No.6, 2006.6, 359-366. 3. Effect of Heat-Treatment
Temperature on the Osteoconductivity of the Apatite Derived from Bovine Bone, Key Engineering Materials Vols. 309-311
(2006) pp 41-44 4. Bone reaction to bovine hydroxyapatite grafted in the mandibular defects of beagle dogs. J Korean Acad
Periodontol. 2006;36:39-49. 5. Maxillary sinus floor augmentation using deproteinized bovine bone-derived bone graft mate-
rial (OCB-B®). Clinical and histologic findings in human. The Journal of the Korean Dental Association. 2007; 45(8): 491-499.
6. Periodontal Repair on Intrabony Defects treated with Anorganic Bovine-derived XenoGraft. J Korean Acad Periodontol.
2007; 37(3): 489-496. 7. The comparative study - the regenerative effect depends on size of bone graft material in bone loss
site around dental implant. J Korean Acad Periodontol. 2008;38:493-502. 8. A comparative analysis of basic characteristics
06 | Instradent products
of several deproteinized bovine bone substitutes. J Korean Acad Periodontol. 2009;39:149-156. 9. A radiographical study
on the changes in height of grafting materials after sinus lift: a comparison between two types of xenogenic materials, J
Periodontal Implant Sci 2010;40:25-32 10. Comparative study of two collagen membranes for guided tissue regeneration
therapy in periodontal intrabony defects: a randomized clinical trial; Young-Mi Chung, Jue-Yeon Lee, Seong-Nyum Jeong;
J Periodontal Implant Sci 2014; 44:194-200 11. Biological effects of a porcine-derived collagen membrane on intrabony
defects; Chang-Kyun Lee, Ki-Tae Koo, Tae-Il Kim, Yang-Jo Seol, Yong-Moo Lee, In-Chul Rhyu, Young Ku, Chong-Pyoung
Chung1, Yoon-Jeong Park, Jue-Yeon Lee; J Periodontal Implant Sci 2010;40:232-238 12. Speer DP, Chvapil M, Eskelson CD,
Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res
1980;14:753-64. 13. Locci P, Calvitti M, Belcastro S, Pugliese M, Guerra M, Marinucci L, et al. Phenotype expression of gingi-
val fibroblasts cultured on membranes used in guided tissue regeneration.J Periodontol 1997;68:857-63. 14. Data on files
Thickness / surface Size
280 ± 90 microns / smooth 30 × 25 mm
280 ± 90 microns / smooth 25 × 15 mm
280 ± 90 microns / smooth 20 × 10 mm
Storage
controlled temperature below 23°C, dry place
Shelf life
3 years
Instradent® Membrane
Instradent products | 07
INTERNATIONAL HEADQUARTERS
INSTRADENT
Peter Merian-Weg 12
CH-4002 Basel, Switzerland
Phone: +41 (0)61 965 11 11
Fax: +41 (0)61 965 11 01
E-mail: [email protected]
Web: www.instradent.com